SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-04-083435
Filing Date
2004-05-10
Accepted
2004-05-10 14:11:19
Documents
4
Period of Report
2004-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR CORTEX PHARMACEUTICALS d10q.htm 10-Q 209034
2 CERTIFICATION BY CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 9563
3 CERTIFICATION BY CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 9419
4 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 dex32.htm EX-32 5946
  Complete submission text file 0001193125-04-083435.txt   235896
Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718
Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-16467 | Film No.: 04792269
SIC: 2834 Pharmaceutical Preparations